Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Chemoprotective drugs, such as dexrazoxane, may protect normal
cells from the side effects of chemotherapy.
PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy
with or without dexrazoxane in treating children who have Hodgkin's disease.